キノロンの世界市場レポート 2025

キノロン市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.4％で646億1,000万米ドルに成長します。予測期間の成長は、新興疾患、規制の変更、世界の保健政策、抗生物質耐性の上昇、市場拡大戦略などに起因すると考えられます。予測期間の主な動向には、新製品開発、規制状況の変化などがあります。

感染症罹患率の上昇がキノロン市場の成長を大きく牽引しています。感染症とは、寄生虫、真菌、細菌、ウイルスなどの微生物によって引き起こされる病気を指します。キノロンは、結核や尿路感染症など、細菌によって引き起こされるさまざまな感染症の治療に一般的に使用されています。例えば、スイスに本部を置く保健機関である世界保健機関（WHO）が2023年11月に発表した「世界結核レポート」によると、2022年に新たに結核と診断された世界の患者数は750万人に達し、2021年の640万人から増加しました。したがって、感染症罹患率の上昇はキノロン市場を推進すると予想されます。

抗菌薬耐性の脅威の高まりは、今後キノロン市場をさらに押し上げると予測されます。抗菌薬耐性（AMR）とは、細菌、ウイルス、寄生虫、真菌を含む微生物が抗菌薬の効果に耐える能力を指します。キノロンの抗菌薬には幅広い活性スペクトルがあり、さまざまな細菌に有効です。様々な組織に浸透する能力を持つため、特定のタイプの感染症に処方されることが多く、他の治療法が限られている場合に好ましい選択肢となります。例えば、2024年7月、米国を拠点とする非営利団体である疾病対策予防センター（Centers for Disease Control and Prevention）の報告によると、抗菌薬耐性感染症は2021年から2022年の間に20％急増し、C. aurisの臨床例は2021年と比較して2022年に増加しています。したがって、抗菌薬耐性の脅威の高まりがキノロン市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界キノロンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界のキノロン市場：成長率分析
• 世界のキノロン市場の実績：規模と成長, 2019-2024
• 世界のキノロン市場の予測：規模と成長, 2024-2029, 2034F
• 世界キノロン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のキノロン市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ノルフロキサシン
• オフロキサシン
• シプロフロキサシン
• ゲミフロキサシン
• その他のタイプ
• 世界のキノロン市場病原体の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• グラム陽性病原体
• グラム陰性病原体
• 世界のキノロン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のキノロン市場ノルフロキサシンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 適応症
• 剤形
• 世界のキノロン市場、オフロキサシンの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 適応症
• 剤形
• 世界のキノロン市場シプロフロキサシンの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 適応症
• 剤形
• 世界のキノロン市場、ゲミフロキサシンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 適応症
• 剤形
• 世界のキノロン市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• さまざまな処方
• 適応症

第7章 地域別・国別分析

• 世界のキノロン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のキノロン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• キノロン市場：競合情勢
• キノロン市場：企業プロファイル
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • LG Life Sciences Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Pfizer Inc.
• Viatris Inc.
• Lupin Limited
• Hikma Pharmaceuticals plc
• Zydus Group
• KYORIN Holdings Inc.
• Teva Pharmaceutical Industries Ltd.
• GSK plc
• Zee Laboratories
• Cipla Ltd.
• Geo Pharma Pvt. Ltd.
• Finecure Pharmaceuticals
• Novus
• AstraZeneca plc
• Sun Pharmaceutical Industries Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• キノロン市場2029：新たな機会を提供する国
• キノロン市場2029：新たな機会を提供するセグメント
• キノロン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Quinolones are a class of bactericidal antibiotics that exhibit the capability to directly kill bacterial cells, targeting both gram-positive and gram-negative bacteria. They are employed in the treatment of various infectious diseases caused by bacteria.

The primary types of quinolones include norfloxacin, ofloxacin, ciprofloxacin, gemifloxacin, and others. Norfloxacin, specifically a fluoroquinolone, is utilized for the treatment of diverse bacterial infections. Its applications extend to addressing conditions such as conjunctivitis and urinary tract infections, targeting both gram-positive and gram-negative pathogens. Quinolones are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

The quinolones market research report is one of a series of new reports from The Business Research Company that provides, quinolones market statistics, including, quinolones industry global market size, regional shares, competitors with a quinolones market share, detailed, quinolones market segments, market trends and opportunities, and any further data you may need to thrive in the quinolones industry. This, quinolones market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The quinolones market size has grown steadily in recent years. It will grow from $50.05 billion in 2024 to $52.39 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to antibiotic demand and usage, regulatory approvals, research and development, competitive landscape, patent expirations.

The quinolones market size is expected to see strong growth in the next few years. It will grow to $64.61 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to emerging diseases, regulatory changes, global health policies, rising antibiotic resistance, and market expansion strategies. Major trends in the forecast period include new product development, and changes in the regulatory landscape.

The rising incidence of infectious diseases is significantly driving the growth of the quinolones market. Infectious diseases refer to illnesses caused by microbes such as parasites, fungi, bacteria, and viruses. Quinolones are commonly used to treat a range of infectious diseases caused by bacteria, including tuberculosis and urinary tract infections. For instance, in November 2023, the Global Tuberculosis Report published by the World Health Organization, a health agency based in Switzerland, noted that the global number of newly diagnosed TB cases reached 7.5 million in 2022, an increase from 6.4 million in 2021. Therefore, the rise in infectious disease incidence is expected to propel the quinolones market.

The growing threat of antimicrobial resistance is anticipated to further boost the quinolones market in the future. Antimicrobial resistance (AMR) refers to the ability of microorganisms, including bacteria, viruses, parasites, and fungi, to withstand the effects of antimicrobial drugs. Quinolones have a broad spectrum of activity, making them effective against various bacteria. They are often prescribed for specific types of infections due to their ability to penetrate different tissues, becoming a preferred option when other treatments are limited. For instance, in July 2024, a report from the Centers for Disease Control and Prevention, a U.S.-based non-profit organization, indicated that antimicrobial-resistant infections surged by 20% between 2021 and 2022, and clinical cases of C. auris increased in 2022 compared to 2021. Therefore, the escalating threat of antimicrobial resistance is driving the growth of the quinolones market.

A prominent trend in the quinolones market is the emphasis on product innovation by major companies to sustain their market positions. For instance, in January 2023, Viatris, a US-based pharmaceutical company's South Korean branch introduced Dovprela, a novel treatment for drug-resistant tuberculosis. Dovprela, a three-drug regimen comprising bedaquiline, pretomanid, and linezolid (BPaL), offers a more rapid anti-tuberculosis effect, reducing the treatment period from 18-20 months to 5-6 months. This innovation addresses the pressing need for effective and efficient tuberculosis treatments.

Innovative products, such as fluoroquinolone antibiotic eye drops, are being introduced to drive revenues in the quinolones market. Fluoroquinolone antibiotic eye drops, a class of antibiotics targeting bacterial eye infections, contribute to ophthalmic health. For instance, Harrow Health Inc., a US-based pharmaceutical company, launched Vigamox in July 2023. This sterile ophthalmic solution, delivered in a 3-milliliter bottle, is indicated for the prevention of eye infections before and after surgery. Such innovative products cater to diverse medical needs and contribute to the market's growth.

In June 2023, Bausch + Lomb Incorporated, a US-based eye health company, acquired Novartis International AG for an undisclosed amount. Through this acquisition, Bausch + Lomb aims to restructure its pharmaceutical division, enhancing its scale and positioning it at the forefront of addressing ocular surface disorders. The acquisition diversifies Bausch + Lomb's product portfolio, introducing new opportunities such as libvatrep and AcuStream technology. Libvatrep is an experimental compound studied for treating chronic ocular surface pain, while AcuStream technology is an experimental device designed for accurate dosing and delivery of certain topical ophthalmic medications. Novartis International AG, based in Switzerland, is a pharmaceutical company with a global presence.

Major companies operating in the quinolones market include Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, Novus, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.

North America was the largest region in the quinolones market in 2024. The regions covered in the quinolones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the quinolones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The quinolones market consists of sales of bedaquiline. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Quinolones Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on quinolones market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for quinolones ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The quinolones market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Norfloxacin; Ofloxacin; Ciprofloxacin; Gemifloxacin; Other Types
• 2) By Pathogen Type: Gram-Positive Pathogen; Gram-Negative Pathogen
• 3) By Application: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Norfloxacin: Indications; Dosage Forms
• 2) By Ofloxacin: Indications; Dosage Forms
• 3) By Ciprofloxacin: Indications; Dosage Forms
• 4) By Gemifloxacin: Indications; Dosage Forms
• 5) By Other Types: Various Formulations; Indications
• Companies Mentioned: Bayer AG; Novartis AG; Sanofi SA; Merck & Co. Inc.; LG Life Sciences
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Quinolones Market Characteristics

3. Quinolones Market Trends And Strategies

4. Quinolones Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Quinolones Growth Analysis And Strategic Analysis Framework

• 5.1. Global Quinolones PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Quinolones Market Growth Rate Analysis
• 5.4. Global Quinolones Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Quinolones Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Quinolones Total Addressable Market (TAM)

6. Quinolones Market Segmentation

• 6.1. Global Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Norfloxacin
• Ofloxacin
• Ciprofloxacin
• Gemifloxacin
• Other Types
• 6.2. Global Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gram-Positive Pathogen
• Gram-Negative Pathogen
• 6.3. Global Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Quinolones Market, Sub-Segmentation Of Norfloxacin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Indications
• Dosage Forms
• 6.5. Global Quinolones Market, Sub-Segmentation Of Ofloxacin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Indications
• Dosage Forms
• 6.6. Global Quinolones Market, Sub-Segmentation Of Ciprofloxacin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Indications
• Dosage Forms
• 6.7. Global Quinolones Market, Sub-Segmentation Of Gemifloxacin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Indications
• Dosage Forms
• 6.8. Global Quinolones Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Various Formulations
• Indications

7. Quinolones Market Regional And Country Analysis

• 7.1. Global Quinolones Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Quinolones Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Quinolones Market

• 8.1. Asia-Pacific Quinolones Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Quinolones Market

• 9.1. China Quinolones Market Overview
• 9.2. China Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Quinolones Market

• 10.1. India Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Quinolones Market

• 11.1. Japan Quinolones Market Overview
• 11.2. Japan Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Quinolones Market

• 12.1. Australia Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Quinolones Market

• 13.1. Indonesia Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Quinolones Market

• 14.1. South Korea Quinolones Market Overview
• 14.2. South Korea Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Quinolones Market

• 15.1. Western Europe Quinolones Market Overview
• 15.2. Western Europe Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Quinolones Market

• 16.1. UK Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Quinolones Market

• 17.1. Germany Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Quinolones Market

• 18.1. France Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Quinolones Market

• 19.1. Italy Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Quinolones Market

• 20.1. Spain Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Quinolones Market

• 21.1. Eastern Europe Quinolones Market Overview
• 21.2. Eastern Europe Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Quinolones Market

• 22.1. Russia Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Quinolones Market

• 23.1. North America Quinolones Market Overview
• 23.2. North America Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Quinolones Market

• 24.1. USA Quinolones Market Overview
• 24.2. USA Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Quinolones Market

• 25.1. Canada Quinolones Market Overview
• 25.2. Canada Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Quinolones Market

• 26.1. South America Quinolones Market Overview
• 26.2. South America Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Quinolones Market

• 27.1. Brazil Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Quinolones Market

• 28.1. Middle East Quinolones Market Overview
• 28.2. Middle East Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Quinolones Market

• 29.1. Africa Quinolones Market Overview
• 29.2. Africa Quinolones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Quinolones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Quinolones Market Competitive Landscape And Company Profiles

• 30.1. Quinolones Market Competitive Landscape
• 30.2. Quinolones Market Company Profiles
  • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. LG Life Sciences Overview, Products and Services, Strategy and Financial Analysis

31. Quinolones Market Other Major And Innovative Companies

• 31.1. Pfizer Inc.
• 31.2. Viatris Inc.
• 31.3. Lupin Limited
• 31.4. Hikma Pharmaceuticals plc
• 31.5. Zydus Group
• 31.6. KYORIN Holdings Inc.
• 31.7. Teva Pharmaceutical Industries Ltd.
• 31.8. GSK plc
• 31.9. Zee Laboratories
• 31.10. Cipla Ltd.
• 31.11. Geo Pharma Pvt. Ltd.
• 31.12. Finecure Pharmaceuticals
• 31.13. Novus
• 31.14. AstraZeneca plc
• 31.15. Sun Pharmaceutical Industries Ltd.

32. Global Quinolones Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Quinolones Market

34. Recent Developments In The Quinolones Market

35. Quinolones Market High Potential Countries, Segments and Strategies

• 35.1 Quinolones Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Quinolones Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Quinolones Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer